The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers

I Cavallari, F Ciccarese, E Sharova, L Urso… - Cancers, 2021 - mdpi.com
Simple Summary MicroRNAs (miRNAs) are small RNA molecules that regulate gene
expression by blocking translation or inducing degradation of specific gene transcripts. The …

Current status of artificial intelligence applications in urology and their potential to influence clinical practice

J Chen, D Remulla, JH Nguyen, A Dua, Y Liu… - BJU …, 2019 - Wiley Online Library
Objective To investigate the applications of artificial intelligence (AI) in diagnosis, treatment
and outcome predictionin urologic diseases and evaluate its advantages over traditional …

Artificial intelligence and its impact on urological diseases and management: a comprehensive review of the literature

BMZ Hameed, AVL S. Dhavileswarapu… - Journal of Clinical …, 2021 - mdpi.com
Recent advances in artificial intelligence (AI) have certainly had a significant impact on the
healthcare industry. In urology, AI has been widely adopted to deal with numerous …

miR‐21‐5p, miR‐141‐3p, and miR‐205‐5p levels in urine—promising biomarkers for the identification of prostate and bladder cancer

N Ghorbanmehr, S Gharbi, E Korsching… - The …, 2019 - Wiley Online Library
Background Early detection of cancers improves patients' survival and decreases the
treatment cost. Unfortunately, the current methods for diagnosis of bladder and prostate …

The translational potential of microRNAs as biofluid markers of urological tumours

A Fendler, C Stephan, GM Yousef… - Nature Reviews …, 2016 - nature.com
MicroRNAs (miRNAs) are secreted by cells in vesicles, bound in a ribonucleoprotein
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …

Role of exosomal miRNA in bladder cancer: a promising liquid biopsy biomarker

XM Piao, EJ Cha, SJ Yun, WJ Kim - International journal of molecular …, 2021 - mdpi.com
Bladder cancer (BCa) is the most prevalent neoplasia of the urinary tract. Unfortunately,
limited improvements in effective BCa management have meant that it remains a …

Increased accuracy of a novel mRNA‐based urine test for bladder cancer surveillance

R Pichler, J Fritz, G Tulchiner, G Klinglmair… - Bju …, 2018 - Wiley Online Library
Objectives To evaluate the diagnostic accuracy of the Xpert Bladder Cancer (BC) Monitor,
compared with cystoscopy and cytology in the oncological follow‐up of non‐muscle …

Urinary markers in bladder cancer: an update

G Santoni, MB Morelli, C Amantini, N Battelli - Frontiers in oncology, 2018 - frontiersin.org
Bladder cancer (BC) is ones of the most common cancer worldwide. It is classified in muscle
invasive (MIBC) and muscle non-invasive (NMIBC) BC. NMIBCs frequently recur and …

Liquid biopsy biomarkers in bladder cancer: a current need for patient diagnosis and monitoring

I Lodewijk, M Dueñas, C Rubio… - International journal of …, 2018 - mdpi.com
Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence
and recurrence rates, as well as the limited advances in effective disease management …

Transforming disease diagnosis and management: a comprehensive review of AI-driven urine analysis in clinical medicine

VK Shukla, M Sudhi, DK Shetty, S Banthia… - Engineered …, 2023 - espublisher.com
Urinalysis is a significant diagnostic tool for the detection of various diseases. The recent
surge in the applications of artificial intelligence (AI) has revolutionized the medical industry …